Welcome to RECONNECT Fragile X Study Website.
Currently there are no approved therapies for the treatment of Fragile X syndrome, a rare genetic disorder.
This research study is currently enrolling children and adolescents ages 3 to 17 years of age with Fragile X syndrome.
To see if someone you love may be able to participate, please apply to learn more.
Children Are Our Commitment
Learn more about a clinical trial evaluating investigational cannabidiol (CBD) gel to see if it helps behavioural issues related to Fragile X syndrome.
Qualified participants are:
- Between 3 and 17 years of age
- Diagnosed via genetic testing, with Fragile X syndrome
- In generally good health
